Drugs

Examining the opioid, cannabis and other drug industries.

The Examination
The Examination

In the US, opioid-maker Purdue is bankrupt. Its global counterparts make millions.

Tactics used to persuade U.S. doctors that potent painkillers could be safely prescribed have been used abroad, an investigation shows.

September 17, 2024
The Examination

Chronic pain and opioids: a crisis goes global

With one in four adults worldwide affected by persistent pain, experts urge a shift away from treatment with opioids, which carry risks of addiction and overdose.

September 17, 2024
The Examination

Marijuana or hemp? Most drug tests can’t tell the difference.

People in states where marijuana remains illegal are failing drug tests and facing major repercussions even though they say it is legal hemp that they are consuming.

August 14, 2024
The Examination

Future of delta-8 in question as lawmakers and hemp industry square off

Architect of hemp law says she ‘did not know’ that highly-potent compounds could be made from the plant.

June 27, 2024
The Examination

Sales of delta-8 and other hemp products have soared. So have calls to poison control centers.

 As a new kind of legal weed takes the U.S. by storm, regulators, law enforcement and even industry voices are calling for more oversight.

April 18, 2024

Tell us about your experience with delta-8 and other hemp products.

Nano Delta 9 gummies

Sales of delta-8 and other hemp products are booming. Here’s what to know.

Marijuana for recreational use remains outlawed in half of the U.S. — yet it is easy to buy gummies, vapes and other products that deliver a high in many of those same states.

April 18, 2024